Parenteral Nutrition Market By Product Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Parenteral Nutrition Market
Parenteral Nutrition Market: By Product Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals) & By Region-Forecast (2016-2021)
Report Code : HCR 0259
Updated Date: 27 January, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Parenteral Nutrition Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Parenteral Nutrition Market– Market Forces
   4.1. Drivers
      4.1.1. Growing population of cancer patients
      4.1.2. Rise in the awareness prevalence of chronic medical conditions
      4.1.3. Increasing awareness by various government bodies
      4.1.4. Spur in demand for peripheral intravenous nutrition
      4.1.5. Increasing incidences of Crohn’s disease and ulcerative colitis
   4.2. Restraints
      4.2.1. Growing preference for enteral nutrition
      4.2.2. Risk of side effects and infection
      4.2.3. Higher cost of research and develpment
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of parenteral nutrition
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Parenteral Nutrition Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Parenteral Nutrition Market, By Nutrition Type
   6.1. Carbohydrates
   6.2. Parenteral Lipid Emulsion
   6.3. Single Dose Amino Acid Solution
   6.4. Trace Elements
   6.5. Vitamins and Minerals
7. Parenteral Nutrition Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Parenteral Nutrition – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Otsuka Pharmaceutical Factory Inc.
   9.2. SichuanKelun Pharmaceutical Co., Ltd.
   9.3. B. Braun Melsungen AG
   9.4. Grifols International S.A.
   9.5. Baxter International Inc.
   9.6. Fresenius Kabi AG
   9.7. Hospira Inc.
   9.8. Actavis Inc.
   9.9. Fresenius Kabi AG
   9.10. Bayer AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Parenteral nutrition is a method of getting nutrition into the body through the veins. It is delivered either peripherally or centrally, through the superior vena cava, this helps in crossing the first-pass effect. Globally, growing population of cancer patients, rise in the awareness prevalence of chronic medical conditions, increasing awareness by various government bodies, spur in demand for peripheral intravenous nutrition, and increasing incidences of Crohn’s disease and ulcerative colitis are the prime growth drivers of parenteral nutrition market. In addition, increase in adoption of parenteral nutrition, and emerging economies such as China, India and others will create new opportunities for parenteral nutrition market. However, higher cost of the research and development, growing preference for enteral nutrition, and risk of side effects and infection are the key restraints for parenteral nutrition market.

This report identifies the global parenteral nutrition market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to parenteral nutrition market.
 
Parenteral Nutrition Market

Geographically, North America dominated the parenteral nutrition market, and Asia Pacific is projected to have the fastest growth, owing to rapidly increasing population prone to malnutrition, rise in awareness among people and modernising of healthcare infrastructure in developing nations such as China and India in this region. Among all nutrition type, single dose amino acid solution has the highest market share in parenteral nutrition market, owing to lower risk of side effects and can be consumed by individuals of all ages.

This report segments parenteral nutrition market on the basis of product type, and regional market as follows:
  • Parenteral Nutrition Market, By Nutrition Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the parenteral nutrition market. Some of the major companies’ profiles in detail are as follows:

  • Otsuka Pharmaceutical Factory Inc.
  • SichuanKelun Pharmaceutical Co., Ltd.
  • B. Braun Melsungen AG
  • Grifols International S.A.
  • Baxter International Inc.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll